Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Cardiopulmonary Resuscitation in Patients With Acquired Immunodeficiency Syndrome

Cardiopulmonary Resuscitation in Patients With Acquired Immunodeficiency Syndrome Abstract To the Editor.—It is with interest that I read the article by Raviglione et al1 in a recent issue of the Archives. While it is interesting that patients with acquired immunodeficiency syndrome have a less favorable outcome from cardiopulmonary resuscitation than other patients, it would be satisfying to have some explanation for the difference. One does not need to be an especially erudite physician to understand the risks that cardiopulmonary resuscitation poses to the rescuer, nor a particularly perspicacious physician to fear the consequences of human immunodeficiency virus infection. I therefore wonder whether some difference in the vigor of the cardiopulmonary resuscitation effort might be responsible. One might look, for example, at how long it took for (1) artificial ventilation to be started; (2) how long it took for an intravenous access to be secured, and (3) how long it took for blood gas analyses to be obtained. References 1. Raviglione MC, Battan R, Taranta A. Cardiopulmonary resuscitation in patients with the acquired immunodeficiency syndrome . Arch Intern Med . 1988;148:2602-2605.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Cardiopulmonary Resuscitation in Patients With Acquired Immunodeficiency Syndrome

Archives of Internal Medicine , Volume 149 (10) – Oct 1, 1989

Cardiopulmonary Resuscitation in Patients With Acquired Immunodeficiency Syndrome

Abstract

Abstract To the Editor.—It is with interest that I read the article by Raviglione et al1 in a recent issue of the Archives. While it is interesting that patients with acquired immunodeficiency syndrome have a less favorable outcome from cardiopulmonary resuscitation than other patients, it would be satisfying to have some explanation for the difference. One does not need to be an especially erudite physician to understand the risks that cardiopulmonary resuscitation poses to the...
Loading next page...
 
/lp/american-medical-association/cardiopulmonary-resuscitation-in-patients-with-acquired-U0itYyO00s
Publisher
American Medical Association
Copyright
Copyright © 1989 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1989.00390100166037
Publisher site
See Article on Publisher Site

Abstract

Abstract To the Editor.—It is with interest that I read the article by Raviglione et al1 in a recent issue of the Archives. While it is interesting that patients with acquired immunodeficiency syndrome have a less favorable outcome from cardiopulmonary resuscitation than other patients, it would be satisfying to have some explanation for the difference. One does not need to be an especially erudite physician to understand the risks that cardiopulmonary resuscitation poses to the rescuer, nor a particularly perspicacious physician to fear the consequences of human immunodeficiency virus infection. I therefore wonder whether some difference in the vigor of the cardiopulmonary resuscitation effort might be responsible. One might look, for example, at how long it took for (1) artificial ventilation to be started; (2) how long it took for an intravenous access to be secured, and (3) how long it took for blood gas analyses to be obtained. References 1. Raviglione MC, Battan R, Taranta A. Cardiopulmonary resuscitation in patients with the acquired immunodeficiency syndrome . Arch Intern Med . 1988;148:2602-2605.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Oct 1, 1989

References